Evidence map›Paper›PMID 29915869›Full record

Trial reportEuropean journal of pediatrics2018

Using a high-flow nasal cannula provides superior results to OxyMask delivery in moderate to severe bronchiolitis: a randomized controlled study.

Ayse Betul Ergul, Emrah Calıskan, Hasan Samsa, Ikbal Gokcek, Ali Kaya, Gozde Erturk Zararsiz, Yasemin Altuner Torun

Abstract readClinical Trial, Phase IVComparative StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 9 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 9 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Respiratory support in paediatric patients with bronchiolitis: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  3. Pooled it
  4. High-flow nasal cannula therapy for infants with bronchiolitis.The Cochrane database of systematic reviews · 2024
    Pooled it
  5. High flow nasal cannula for respiratory support in term infants.The Cochrane database of systematic reviews · 2023
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Superiority of OxyMaskEuropean journal of pediatrics · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ayse Betul ErgulDepartment of Pediatric Intensive Care Unit, University of Health Sciences, Kayseri Training and Research Hospital, Ataturk Bulvarı, 38030, Kayseri, Turkey. abergul@hotmail.com.ORCID http://orcid.org/0000-0003-1088-5845
Emrah CalıskanDepartment of Pediatrics, University of Health Sciences, Kayseri Training and Research Hospital, Kayseri, Turkey.
Hasan SamsaDepartment of Pediatric Intensive Care Unit, University of Health Sciences, Kayseri Training and Research Hospital, Ataturk Bulvarı, 38030, Kayseri, Turkey.
Ikbal GokcekDepartment of Pediatric Intensive Care Unit, University of Health Sciences, Kayseri Training and Research Hospital, Ataturk Bulvarı, 38030, Kayseri, Turkey.
Ali KayaDepartment of Pediatric Intensive Care Unit, University of Health Sciences, Kayseri Training and Research Hospital, Ataturk Bulvarı, 38030, Kayseri, Turkey.
Gozde Erturk ZararsizDepartment of Biostatistics, Erciyes University School of Medicine, Kayseri, Turkey.
Yasemin Altuner TorunDepartment of Pediatric Hematology, University of Health Sciences, Kayseri Training and Research Hospital, Kayseri, Turkey.
Kayseri Eğitim ve Araştırma Hastanesi · TRErciyes University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effectiveness of using a face mask with a small diffuser for oxygen delivery (OxyMask) was compared to use of a high-flow nasal cannula (HFNC) in patients with moderate or severe bronchiolitis.The study population in this open, phase 4, randomized controlled trial consisted of 60 patients aged 1-24 months diagnosed with moderate or severe bronchiolitis and admitted to an intensive care unit (ICU) for oxygen therapy. The patients were randomized into two groups according to the method of oxygen delivery: a diffuser mask group and an HFNC group.There were seven failures in the mask group and none in the HFNC group. The survival probability differed significantly between the two treatment methods (p = 0.009).Time to weaning off oxygen therapy was 56 h in the HFNC group and 96 h in the mask group (p < 0.001).Conclusion: HFNC use decreased the treatment failure rate and the duration of both oxygen therapy and ICU treatment compared to the diffuser mask, which implies that an HFNC should be the first choice for treating patients admitted to the ICU with severe bronchiolitis. What is known: • A high-flow nasal cannula (HFNC) does not significantly reduce the time on oxygen compared to standard therapy in children with moderate to severe bronchiolitis. Observational studies show that, since the introduction of HFNC, fewer children with bronchiolitis need intubation. For children with moderate to severe bronchiolitis there is no proof of its benefit. What Is New: • In children with moderate to severe bronchiolitis, HFNC provides faster and more effective improvement than can be achieved with a diffuser mask.

Indexed as

Administration, IntranasalBronchiolitisCannulaChild, PreschoolFemaleHumansInfantIntensive Care Units, PediatricLength of StayMaleMasksOxygen Inhalation TherapySurvival AnalysisTreatment FailureBronchiolitisDiffuser maskHigh-flow nasal oxygenOxyMaskPediatric intensive care unit

Identifiers

PMID29915869
OpenAlexW2809459396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.